YTS109 cell

DRUG9 trials

Sponsors

China Immunotech (Beijing) Biotechnology Co., Ltd., Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Children's Hospital of Fudan University

Conditions

ANCA Associated Vasculitis (AAV)Anti-Neutrophil Cytoplasmic Antibody-Associated VasculitisAntiphospholipid SyndromeAntiphospholipid Syndrome (APS)Autoimmune Hemolytic AnemiaDiffuse Systemic SclerosisIdiopathic Inflammatory Myopathies (IIMs)IgG4-Related Diseases

Phase 1

A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases

RecruitingNCT06978647

China Immunotech (Beijing) Biotechnology Co., Ltd.Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Antiphospholipid Syndrome (APS), IgG4-Related Diseases +5

Start: 2025-05-19End: 2027-05-19Target: 12Updated: 2025-07-14

A Study of YTS109 Cell in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia

CompletedNCT07075484

China Immunotech (Beijing) Biotechnology Co., Ltd.Autoimmune Hemolytic Anemia

Start: 2025-01-15End: 2026-02-27Updated: 2026-03-02

A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases

RecruitingNCT07104721

China Immunotech (Beijing) Biotechnology Co., Ltd.Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Antiphospholipid Syndrome (APS), Inflammatory Myopathy +3

Start: 2025-08-04End: 2028-12-30Target: 18Updated: 2026-03-02

A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases

RecruitingNCT07123519

China Immunotech (Beijing) Biotechnology Co., Ltd.Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Antiphospholipid Syndrome (APS), Inflammatory Myopathy +3

Start: 2025-08-13End: 2027-08-13Target: 18Updated: 2026-03-02

An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases

RecruitingNCT07236762

China Immunotech (Beijing) Biotechnology Co., Ltd.Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Antiphospholipid Syndrome, Inflammatory Myopathy +3

Start: 2025-11-24End: 2027-11-24Target: 18Updated: 2026-03-04

Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases

RecruitingNCT07236801

China Immunotech (Beijing) Biotechnology Co., Ltd.Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Antiphospholipid Syndrome, Inflammatory Myopathy +3

Start: 2025-11-13End: 2027-11-13Target: 18Updated: 2026-03-02

A Study of YTS109 Cell in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia

Not yet recruitingNCT07287930

Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyAutoimmune Hemolytic Anemia

Start: 2025-12-25End: 2027-12-26Target: 13Updated: 2025-12-17

YTS109 in Pediatric Relapsed/Refractory Autoimmune Diseases

Not yet recruitingNCT07439029

Children's Hospital of Fudan UniversityANCA Associated Vasculitis (AAV), Antiphospholipid Syndrome (APS), Diffuse Systemic Sclerosis +3

Start: 2026-03-01End: 2030-07-01Target: 12Updated: 2026-02-27

Research on YTS109 Cell in Patients With Recurrent/Refractory Autoimmune Hemolytic Anemia

Not yet recruitingNCT07453836

China Immunotech (Beijing) Biotechnology Co., Ltd.Autoimmune Hemolytic Anemia

Start: 2026-03-18End: 2028-03-18Target: 13Updated: 2026-03-06